Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Perspectives

Vol. 1 No. 2 (2022): May 2022

Exacerbation of Chronic Obstructive Pulmonary Disease during Outbreak Pandemic

DOI
https://doi.org/10.55048/jpns.v1i2.19
Submitted
March 21, 2022
Published
2022-05-05

Abstract

Chronic obstructive pulmonary disease (COPD) during a pandemic is of particular concern because it can worsen the disease. The COVID-19 pandemic is known to cause many deaths and a high spread of the virus. This is a concern for people with COPD regarding the risk of death. The indicator of worsening COPD symptoms is when patients with COPD need to be hospitalized. During the pandemic outbreak, social distancing, use of face masks, and lockdown were implemented. Several studies have reported reduced hospital admissions for COPD exacerbations. It is necessary to intervene judiciously to solve the problem in order to maintain the stability of COPD patients.

References

  1. Alqahtani Id, J. S., Oyelade, T., Aldhahir, A. M., Gonç Alves Mendes, R., Alghamdiid, S. M., Miravitllesid, M., Mandal, S., & Hurst, J. R. (2021). Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis. PLOSONE, 16(8). https://doi.org/10.1371/journal.pone.0255659
  2. Alsallakh, M. A., Sivakumaran, S., Kennedy, S., Vasileiou, E., Lyons, R. A., Robertson, C., Sheikh, A., & Davies, G. A. (2021). Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales. BMC Medicine, 19(1), 124. https://doi.org/10.1186/s12916-021-02000-w
  3. Beltramo, G., Cottenet, J., Mariet, A.-S., Georges, M., Piroth, L., Tubert-Bitter, P., Bonniaud, P., & Quantin, C. (2021). Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study. European Respiratory Journal, 58(6), 2004474. https://doi.org/10.1183/13993003.04474-2020
  4. Cosio, B. G., Shafiek, H., Toledo-Pons, N., Iglesias, A., Barcelo, M., Represas-Represas, C., Comeche, L., Catalan, P., Fernandez-Villar, A., Lopez-Campos, J. L., Echave-Sustaeta, J., & Soler-Cataluna, J. J. (2021). Characterization of COPD admissions during the first COVID-19 outbreak. International Journal of COPD, 16(May), 1549–1554. https://doi.org/10.2147/COPD.S312493
  5. Durdevic, M., Arora, Al., Durdevic, D., Constanta Stan, A., & Naaraayan, A. (2021). Acute COPD Exacerbation After The Second Dose of COVID-19 Vaccine. Chest, 160(4), A1760. https://doi.org/10.1016/j.chest.2021.07.1603
  6. Farrugia, Y., Paul, B., Meilak, S., Grech, N., Asciak, R., Camilleri, L., Montefort, S., & Zammit, C. (2021). The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta. Pulmonary Medicine, 1–7. https://doi.org/10.1155/2021/5533123
  7. GOLD. (2022). Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease (2022 Report).
  8. Huh, K., Kim, Y. E., Ji, W., Kim, D. W., Lee, E. J., Kim, J. H., Kang, J. M., & Jung, J. (2021). Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: A nationwide claims study. Thorax, 76(9), 939–941. https://doi.org/10.1136/thoraxjnl-2020-216526
  9. Lawless, M., Burgess, M., & Bourke, S. (2022). Impact of COVID-19 on Hospital Admissions for COPD Exacerbation: Lessons for Future Care. https://doi.org/10.3390/medicina58010066
  10. Mallik, U., Mahmud, R., Azad, S., Moniruzzaman, Khatun, T., Rafiquzzaman, M., Poddar, S. K., Hoque, M. M., Miah, T., & Rahman, M. (2022). SARS-CoV-2 Infection and Risk Stratification among Healthcare Workers in the Largest COVID-19 Dedicated Tertiary Care Hospital in Dhaka, Bangladesh. Journal of Medicine, 23(1), 5–12. https://doi.org/10.3329/jom.v23i1.57930
  11. McAuley, H., Hadley, K., Elneima, O., Brightling, C. E., Evans, R. A., Steiner, M. C., & Greening, N. J. (2021). COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Research, 7(1), 00718–02020. https://doi.org/10.1183/23120541.00718-2020
  12. Montagnani, A., Mathieu, G., Pomero, F., Bertù, L., Manfellotto, D., Campanini, M., Fontanella, A., Sposato, B., Dentali, F., Bonzini, M., Greco, A., Orlandini, F., Panuccio, D., Pietrantonio, F., & Sciascera, A. (2020). Hospitalization and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD): An Italian population-based study. European Review for Medical and Pharmacological Sciences, 24(12), 6899–6907. https://doi.org/10.26355/eurrev_202006_21681
  13. Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Marc, G. P., Moreira, E. D., Zerbini, C., Bailey, R., Swanson, K. A., Roychoudhury, S., Koury, K., Li, P., Kalina, W. V., Cooper, D., Frenck, R. W., Hammitt, L. L., … Gruber, W. C. (2020). Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. The New England Journal of Medicine, 383(27), 2603–2615. https://doi.org/10.1056/NEJMoa2034577
  14. Reyes-Sánchez, F., Basto-Abreu, A., Torres-Alvarez, R., Canto-Osorio, F., González-Morales, R., Dyer-Leal, D. D., López-Ridaura, R., Zaragoza-Jiménez, C. A., Rivera, J. A., & Barrientos-Gutiérrez, T. (2022). Fraction of COVID-19 hospitalizations and deaths attributable to chronic diseases. Preventive Medicine, 155, 106917. https://doi.org/10.1016/J.YPMED.2021.106917
  15. Saminan, S., Julisafrida, L., Ridwan, M., & Fajri, N. (2022). COVID-19 Pandemic : What Considerations Should Be Taken during the Assessment and Management of COPD Exacerbation ? COVID-19. Open Access Macedonian Journal of Medical Sciences, 10, 71–80. https://doi.org/https://doi.org/10.3889/oamjms.2022.7930
  16. Sarc, I., Lotric Dolinar, A., Morgan, T., Sambt, J., Ziherl, K., Gavric, D., Selb, J., Rozman, A., & Dosenovic Bonca, P. (2022). Mortality, seasonal variation, and susceptibility to acute exacerbation of COPD in the pandemic year: a nationwide population study. Therapeutic Advances in Respiratory Disease, 16, 1–15. https://doi.org/10.1177/17534666221081047
  17. Sheikh, D., Tripathi, N., Chandler, T. R., Furmanek, S., Bordon, J., Ramirez, J. A., & Cavallazzi, R. (2022). Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia. Respiratory Medicine, 191, 106714. https://doi.org/10.1016/j.rmed.2021.106714
  18. So, J. Y., O’Hara, N. N., Kenaa, B., Williams, J. G., DeBorja, C. L., Slejko, J. F., Zafari, Z., Sokolow, M., Zimand, P., Deming, M., Marx, J., Pollak, A. N., & Reed, R. M. (2021). Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections. American Journal of Medicine, 134(10), 1252-1259.e3. https://doi.org/10.1016/j.amjmed.2021.05.008
  19. Trujillo, C., Garnet, B., Zadeh, A. V., Urdaneta, G., & Campos, M. (2021). Decrease in exacerbations during the coronavirus disease 2019 pandemic in a cohort of veterans with COPD. Chronic Obstructive Pulmonary Diseases, 8(4), 572–579. https://doi.org/10.15326/JCOPDF.2021.0234
  20. World Health Organization. (2020). The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
  21. World Health Organization. (2022). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/
  22. Yuan Tan, J., Philip Conceicao, E., En Wee, L., Ying Jean Sim, X., & Venkatachalam, I. (2020). COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax, 1–2. https://doi.org/10.1136/thoraxjnl-2020-216083
  23. Zheng, C., Shao, W., Chen, X., Zhang, B., Wang, G., & Zhang, W. (2022). Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. International Journal of Infectious Diseases, 114, 252–260. https://doi.org/10.1016/j.ijid.2021.11.00

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...